InvestorsHub Logo

idcc2006

04/14/17 1:26 PM

#28116 RE: nep2134 #28115

Roskamp did Alzheimer mice study with anatabine a few years ago. Don't you remember the lady doctor's presentation?

FDA advised Archer to develop drug other than Nilvadipin because it's originally a drug for hypertension. Some people here were hoping Archer to try a mixture of Nilvad and anatabine. I was thinking about the possibility of reverse merger of Archer and Rock Creek.

knuts4oe

04/14/17 10:23 PM

#28118 RE: nep2134 #28115

If a study gets done this year, it should be the one on people with mild to moderate psoriasis. Until the "Mechanism of Action" on human beings is demonstrated, no one is listening to the wondrous claims of what anatabine can do. It has been my experience that when one attempts to explain anatabine's potential as expressed in the use patent, to medical or non medical persons, their eyes begin to glaze over with disbelief in a "I've heard all this before" sort of way. We need incontrovertible proof before anyone pays any attention to anatabine.